Lignocaine 4%, 4 mg/kg, was sprayed onto the larynx and subglottic area of 96 children aged from 2 weeks to 12 years and plasma lignocaine concentrations were measured. While the majority were well within the accepted safe range (4-5 /Ag/ml) occasional concentrations over 8 /Ag/ml appeared in all groups. Simultaneous arterial and venous sampling showed a small but significant difference in the first 10 minutes.
Most of the data in the literature on blood level and toxicity of local anaesthetics have been derived from studies either in adults or from foetal and neonatal pharmacokinetic studies following placental transfer. There is little data from well-controlled studies in children. Our preliminary studies showed occasional high lignocaine levels following laryngeal spray and these occurred in infants. I This is a report of an extension of that study on plasma levels in children.
METHODS
Ninety-six children aged 2 weeks to 12 years undergoing general surgery were included in this study. Premedication with papaveretum and hyoscine 0.4 and 0.008 mg/kg respectively was administered to those older than one year and atropine 0.02 mg/kg to those under one year old. Anaesthesia was induced with thiopentone 5 mg/kg and maintained with tubocurarine 0.75 mg/kg, N20:02 using IPPV. sprayed on the larynx and immediate subglottic area with a Cass needle, just prior to intubation. Venous samples (0.5 ml) were taken at 2, 4, 6, 10, 15,20 and 30 minutes after application of lignocaine. In 12 patients concurrent arterial sampling was carried out.
These samples were analysed using a high performance liquid chromatography assay. 2 The patients were divided into 4 age groups for comparing the effect of age on blood levels. These were less than one year, one and up to three years, three to five years, and greater than five years.
The mean concentration and its standard deviation at each time interval was calculated and Student's {-test applied to compare the mean plasma levels and the times at which they occurred between any pair or age groups, and to also assess the significance of the differences between mean arterial and venous concentration. Table 1 summarises the ages and number of patients included in the study. The data from the first 27 children has been reported previously. The age distribution of the 13 patients in whom peak levels exceeded 8 /Ag/ml and the number of patients in each age group who had simultaneous arterial and venous samples taken are also summarised in the table. In Table 2 the mean peak plasma concentration and the mean time to its occurrence for each of the four age groups is shown. Mean plasma lignocaine concentrations and standard deviations occurring over 30 minutes after topical lignocaine application are shown in Table 3 . Figure 1 graphically displays the mean plasma concentration against time for those children aged between one and three years. There was no significant difference between the peak plasma levels or the time at which they occurred when· airy two age groups were compared. Figure 2 and Table 4 show the mean arterial and venous levels in the 12 patients who had simultaneous arterial and venous sampling. The paired t-test demonstrated a significant difference in plasma levels in the first four sampling intervals (p <0.05), that is up to 10 minutes. (Figure 3 ) on a Luer-lock syringe was used to administer the local anaesthetic so that an accurate dose could be administered. It is difficult to give an accurate dose using a Macintosh spray and the commercially available metred Aerosol tends to produce a gradually decreasing dose as the drug is used up. Anaesthesia and Intensive Care, Vol. 11, No. 1, February, 1983 This study demonstrated a more rapid uptake of local anaesthetic in the younger children although peak plasma levels were similar.
RESULTS
It also showed that high blood levels over (8f../g/ml) appeared randomly in all age groups. In the first 27 patients studied such concentrations only appeared in the very young patients. There are probably several contributing factors to the occasional appearance of high blood levels. These might include the site of administration, whether the patient was breathing spontaneously or being ventilated, and how much local anaesthetic entered the lower airways. The latter would be increased if a patient took a large inspiration following the spray, or possibly if coughing occurred. In this study all patients were paralysed and ventilated.
Although levels exceeding 8 f../g/ml were seen in several patients there was no clinical evidence of toxicity in any of the patients. These results further confirm the wide scatter of blood levels seen in our previous study and by other workers but levels exceeding 8 f../g/ml are rare in these other surveys. [3] [4] [5] [6] It has been claimed that arterial and venous plasma levels differ. In this study it was noted that the difference occurred during the first 10 minutes after which the levels became more comparable.
Scote found using volunteers that it is not only total dose that is important in determining local anaesthetic toxicity but the rate of rise in plasma levels, and by inference the route of administration. Uptake of drugs from the respiratory tract can be as rapid as slow intravenous injection.
There is lack of data equating plasma levels with manifestations of toxicity. No manifestations of toxicity were seen although levels up to about 10 f../g/ml were reached. We conclude that a dose of 4 mg/kg of lignocaine via tracheal spray is safe in anaesthetised children.
